Our Team
The program is conducted by top-tier faculty members who are high-ranking executives at successful global medical device and bio-pharmaceutical companies, as well as accomplished venture capitalists, regulators, attorneys, entrepreneurs and academics from leading US and worldwide healthcare firms.
Adam Dicker
Enterprise Senior Vice President
Dr. Adi Gillat
Founding partner at H-F & Co
Allen Kamer
Managing Partner, OurCrowd Qure
Andrew Weiss
President & CEO at ReCor Medical
Ariel Bayewitz
Vice president, Healtth Economics
Audrey Horn
Product Innovation Director, Anthem Israel
Avner Halperin
CEO of Sheba innovation & commercialization company
Dr. Ayal Shenhav
Head of Hi-Tech & Investment Funds Department
Barry Katz
Barry Katz Ltd
Dr. Benny Zeevi
Program Founder and Director
Brian P. Hopkins
Special Councel, Cooley LLP
Carolyn Hochstadter
E. Carolyn Hochstadter Dicker LLC
David Golan
Co-founder & CTO, Viz.ai
Dr. Dmitry Kuzmin
Founding and managing partner of 4BIO Capital
Dr. Elazer R. Edelman
Professor of Health Sciences and Technology at MIT
Dr. Eyal Zimlichman, MD, MSc
Deputy Director General, Sheba Medical Center
Felix Mahfoud
Associate Prof. & senior physician at Saarland Uni. Hospital
Gila Tolub
Partner, Tel Aviv
Dr. Gur Roshwalb
Partner, aMoon
Jenny Barba
Co-Founder and Managing Partner of Features Capital
John R. Lieberman
PA/PFS Managing Director Perelson Weiner
Jonathan Solomon
CEO BiomX
Keren leshem
CEO of OCON Healthcare
Karin Noy
Emerging Science & Innovation Lead – Israel, Pfizer
Mati Gill
the CEO of AION Labs
Dr. Michal Rosen-Zvi
Director for Healthcare Informatics at IBM Research
Michael Berman
Program Director
Naomi DL Fisher MD
Associate Professor of Medicine, Harvard Medical School
Neil C. Barman M.D
Chief Scientific Officer at ReCor Medical
Dr. Peter Fitzgerald
Director of the Center for Cardiovascular Technology
Rebecca Sternberg
Megama Strategic Design, Co-Founder of Aquafit Intimate
Sigal Admony-Ravid
Strategic Busniess Development Manager, Carelon
